PT1034185E - Composicoes farmaceuticas que contem a pentraxina longa ptx3 - Google Patents
Composicoes farmaceuticas que contem a pentraxina longa ptx3Info
- Publication number
- PT1034185E PT1034185E PT98962665T PT98962665T PT1034185E PT 1034185 E PT1034185 E PT 1034185E PT 98962665 T PT98962665 T PT 98962665T PT 98962665 T PT98962665 T PT 98962665T PT 1034185 E PT1034185 E PT 1034185E
- Authority
- PT
- Portugal
- Prior art keywords
- ptx3
- pharmaceutical compositions
- compositions containing
- long pentraxin
- containing long
- Prior art date
Links
- 101001082142 Homo sapiens Pentraxin-related protein PTX3 Proteins 0.000 title abstract 4
- BFHAYPLBUQVNNJ-UHFFFAOYSA-N Pectenotoxin 3 Natural products OC1C(C)CCOC1(O)C1OC2C=CC(C)=CC(C)CC(C)(O3)CCC3C(O3)(O4)CCC3(C=O)CC4C(O3)C(=O)CC3(C)C(O)C(O3)CCC3(O3)CCCC3C(C)C(=O)OC2C1 BFHAYPLBUQVNNJ-UHFFFAOYSA-N 0.000 title abstract 4
- 102100027351 Pentraxin-related protein PTX3 Human genes 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 239000013598 vector Substances 0.000 abstract 2
- 101100352284 Homo sapiens PITX3 gene Proteins 0.000 abstract 1
- 101100031710 Homo sapiens PTX3 gene Proteins 0.000 abstract 1
- 108700025763 PTX3 Proteins 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- -1 human PTX3 Natural products 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97RM000796A IT1298487B1 (it) | 1997-12-19 | 1997-12-19 | Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale, |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1034185E true PT1034185E (pt) | 2005-07-29 |
Family
ID=11405409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98962665T PT1034185E (pt) | 1997-12-19 | 1998-12-16 | Composicoes farmaceuticas que contem a pentraxina longa ptx3 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8003109B2 (https=) |
| EP (1) | EP1034185B1 (https=) |
| JP (1) | JP4173633B2 (https=) |
| KR (1) | KR100560085B1 (https=) |
| AT (1) | ATE295853T1 (https=) |
| AU (1) | AU756974B2 (https=) |
| CA (1) | CA2315277C (https=) |
| DE (1) | DE69830251T2 (https=) |
| ES (1) | ES2242309T3 (https=) |
| IT (1) | IT1298487B1 (https=) |
| NZ (1) | NZ505063A (https=) |
| PT (1) | PT1034185E (https=) |
| WO (1) | WO1999032516A2 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1298487B1 (it) | 1997-12-19 | 2000-01-10 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale, |
| IT1317927B1 (it) * | 2000-11-03 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie autoimmuni. |
| IT1317930B1 (it) * | 2000-11-08 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patalogie associate ad una alterata attivazione |
| US20040198655A1 (en) * | 2001-08-03 | 2004-10-07 | Alberto Mantovani | Use of long pentraxin ptx3 for treating female infertility |
| US7041648B2 (en) | 2001-08-03 | 2006-05-09 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Compositions and methods for treating female fertility |
| ITRM20020109A1 (it) * | 2002-02-28 | 2003-08-28 | Sigma Tau Ind Farmaceuti | Derivati funzionali della pentraxina lunga ptx3 per preparare un vaccino autologo per la cura dei tumori. |
| ITRM20020191A1 (it) * | 2002-04-08 | 2003-10-08 | Sigma Tau Ind Farmaceuti | Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie tumorali associate ad una alterata att |
| ITRM20030596A1 (it) * | 2003-12-23 | 2005-06-24 | Sigma Tau Ind Farmaceuti | Uso di inibitori della pentraxina lunga ptx3, per la preparazione di un medicamento per la prevenzione e cura di patologie che rispondono all'inibizione dell'attivita' biologica di detta ptx3. |
| ITRM20040223A1 (it) * | 2004-05-07 | 2004-08-07 | Sigma Tau Ind Farmaceuti | Medicamento per il trattamento delle infezioni fungine, in particolare dell'aspergillosi. |
| ITRM20040489A1 (it) * | 2004-10-08 | 2005-01-08 | Sigma Tau Ind Farmaceuti | Pentraxina lunga ptx3 deglicosilata o desialidata. |
| US8076300B2 (en) * | 2006-01-24 | 2011-12-13 | Tecnogen S.P.A. | FGF2-binding peptides and uses thereof |
| EP1832295A1 (en) | 2006-03-10 | 2007-09-12 | Tecnogen S.P.A. | Use of PTX3 for the treatment of viral diseases |
| RS52377B (sr) * | 2006-05-02 | 2012-12-31 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Primena timozina 1, samog ili u kombinaciji sa ptx3 ili ganciklovirom, za lečenje infekcije citomegalovirusom |
| WO2009095403A1 (en) * | 2008-01-29 | 2009-08-06 | Tecnogen S.P.A. | Expression system and uses thereof for the production of human long pentraxin 3 |
| ES2432242T3 (es) | 2009-07-29 | 2013-12-02 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Sistema mejorado de expresión de pentraxina 3 larga humana y sus usos |
| KR101305515B1 (ko) | 2011-06-10 | 2013-09-06 | 경북대학교 산학협력단 | 펜트락신 3 단백질의 파킨슨 질환 진단 용도 |
| WO2013191280A1 (ja) * | 2012-06-22 | 2013-12-27 | 国立大学法人 東京大学 | 全身性炎症反応症候群の治療又は予防剤 |
| TWI528969B (zh) | 2013-06-07 | 2016-04-11 | 國立成功大學 | 胺基酸序列用於製備抑制ｐｔｘ３治療鼻咽癌之醫藥組合物之用途 |
| TWI531375B (zh) | 2015-05-29 | 2016-05-01 | 國立成功大學 | 抑制癌細胞活性之短肽治療劑及含此之醫藥組成物 |
| CN105132459B (zh) * | 2015-09-14 | 2019-01-29 | 武汉市星熠艾克生物医药有限责任公司 | 人类ptx3重组蛋白的制备方法及应用 |
| EP4103592A4 (en) * | 2020-02-12 | 2024-01-10 | BioTissue Holdings Inc. | METHODS OF DESTRUCTING OR INHIBITING THE GROWTH OF CANCER CELLS |
| US20230227511A1 (en) * | 2020-05-14 | 2023-07-20 | Nippon Medical School Foundation | Therapeutic or preventive agent for infectious disease |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1196564B (it) | 1986-08-04 | 1988-11-16 | Sigma Tau Ind Farmaceuti | Impiego di acetil l-carnitina nel trattamento terapeutico delle neuropatie periferiche |
| EP0571442A4 (en) * | 1991-01-14 | 1995-05-03 | Univ New York | PROTEIN TSG-14 INDUCED BY CYTOKINE, DNA ENCODING THE PROTEIN AND USES THEREOF. |
| IT1254687B (it) * | 1992-04-14 | 1995-09-28 | Italfarmaco Spa | Gene inducibile da citochine |
| US6210941B1 (en) | 1997-06-27 | 2001-04-03 | The Trustees Of Boston University | Methods for the detection and isolation of proteins |
| US5632983A (en) | 1994-11-17 | 1997-05-27 | University Of South Florida | Method for treating secondary immunodeficiency |
| US5939423A (en) | 1997-04-16 | 1999-08-17 | Sciclone Pharmaceuticals, Inc. | Treatment of hepatitis B infection with thymosin alpha 1 and famciclovir |
| IT1298487B1 (it) | 1997-12-19 | 2000-01-10 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale, |
| IT1317927B1 (it) | 2000-11-03 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie autoimmuni. |
| IT1317930B1 (it) | 2000-11-08 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patalogie associate ad una alterata attivazione |
| US6872541B2 (en) | 2001-07-25 | 2005-03-29 | Coulter International Corp. | Method and compositions for analysis of pentraxin receptors as indicators of disease |
| US7041648B2 (en) | 2001-08-03 | 2006-05-09 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Compositions and methods for treating female fertility |
| US20040198655A1 (en) | 2001-08-03 | 2004-10-07 | Alberto Mantovani | Use of long pentraxin ptx3 for treating female infertility |
| US20040137544A1 (en) | 2002-10-31 | 2004-07-15 | Roberto Latini | PTX3 as an early prognostic indicator of cardiovascular and cerebrovascular pathologies |
| JP2006524704A (ja) | 2003-04-23 | 2006-11-02 | サイクローン・ファーマシューティカルズ・インコーポレイテッド | アルファチモシンペプチドによる呼吸器ウイルス感染の治療または予防 |
| ITRM20030596A1 (it) | 2003-12-23 | 2005-06-24 | Sigma Tau Ind Farmaceuti | Uso di inibitori della pentraxina lunga ptx3, per la preparazione di un medicamento per la prevenzione e cura di patologie che rispondono all'inibizione dell'attivita' biologica di detta ptx3. |
| ITRM20040489A1 (it) | 2004-10-08 | 2005-01-08 | Sigma Tau Ind Farmaceuti | Pentraxina lunga ptx3 deglicosilata o desialidata. |
| EP1832295A1 (en) | 2006-03-10 | 2007-09-12 | Tecnogen S.P.A. | Use of PTX3 for the treatment of viral diseases |
| RS52377B (sr) | 2006-05-02 | 2012-12-31 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Primena timozina 1, samog ili u kombinaciji sa ptx3 ili ganciklovirom, za lečenje infekcije citomegalovirusom |
-
1997
- 1997-12-19 IT IT97RM000796A patent/IT1298487B1/it active IP Right Grant
-
1998
- 1998-12-16 ES ES98962665T patent/ES2242309T3/es not_active Expired - Lifetime
- 1998-12-16 PT PT98962665T patent/PT1034185E/pt unknown
- 1998-12-16 KR KR1020007006739A patent/KR100560085B1/ko not_active Expired - Fee Related
- 1998-12-16 NZ NZ505063A patent/NZ505063A/xx not_active IP Right Cessation
- 1998-12-16 DE DE69830251T patent/DE69830251T2/de not_active Expired - Lifetime
- 1998-12-16 CA CA2315277A patent/CA2315277C/en not_active Expired - Fee Related
- 1998-12-16 AT AT98962665T patent/ATE295853T1/de active
- 1998-12-16 EP EP98962665A patent/EP1034185B1/en not_active Expired - Lifetime
- 1998-12-16 AU AU17829/99A patent/AU756974B2/en not_active Ceased
- 1998-12-16 JP JP2000525453A patent/JP4173633B2/ja not_active Expired - Fee Related
- 1998-12-16 WO PCT/IT1998/000364 patent/WO1999032516A2/en not_active Ceased
-
2007
- 2007-07-31 US US11/882,180 patent/US8003109B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE295853T1 (de) | 2005-06-15 |
| WO1999032516A3 (en) | 1999-10-28 |
| US8003109B2 (en) | 2011-08-23 |
| JP2002503642A (ja) | 2002-02-05 |
| NZ505063A (en) | 2002-12-20 |
| KR100560085B1 (ko) | 2006-03-13 |
| ES2242309T3 (es) | 2005-11-01 |
| AU1782999A (en) | 1999-07-12 |
| DE69830251T2 (de) | 2005-10-27 |
| EP1034185A2 (en) | 2000-09-13 |
| CA2315277C (en) | 2010-02-23 |
| DE69830251D1 (de) | 2005-06-23 |
| CA2315277A1 (en) | 1999-07-01 |
| KR20010033297A (ko) | 2001-04-25 |
| US20080015153A1 (en) | 2008-01-17 |
| JP4173633B2 (ja) | 2008-10-29 |
| AU756974B2 (en) | 2003-01-30 |
| ITRM970796A1 (it) | 1999-06-19 |
| EP1034185B1 (en) | 2005-05-18 |
| WO1999032516A2 (en) | 1999-07-01 |
| IT1298487B1 (it) | 2000-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1034185E (pt) | Composicoes farmaceuticas que contem a pentraxina longa ptx3 | |
| UA66417C2 (en) | Recombinant adenovirus affecting canines, pharmaceutical composition | |
| ATE286118T1 (de) | Anwendungen für humane nicht autologe, mesenchymale stammzellen | |
| TW428026B (en) | Bifunctional protein, preparation and use | |
| ATE298253T1 (de) | In vivo gentransfermethoden zur wundheilung | |
| NO962791L (no) | Preparater inneholdende nukleinsyrer, deres fremstilling og anvendelse | |
| ES2155702T4 (es) | Construcciones expresivas halteroformes para la terapia genetica. | |
| BR9607583B1 (pt) | plasmìdios procarióticos recombinantes. | |
| IL114904A0 (en) | Adenovirus comprising a gene encoding glutathione peroxidase | |
| ES2153358T3 (es) | Procedimientos para la seleccion de celulas huespedes recombinantes que expresan altos niveles de una proteina deseada. | |
| BR9609853A (pt) | Estruturas com manifestação de p16 e sua aplicação na terapia de cncer. | |
| BR9509172A (pt) | Proteina de via de complemento nativa sequéncia de dna construção de dna conjugado uso de uma proteína processo para reduzir proteina de via de complemento em um mamifero e formulação farmacéutica | |
| AU2164197A (en) | Recombinant adenoviral vectors for human tumour gene therapy | |
| DK1144600T3 (da) | Akt-3-nukleinsyre, polypeptider og anvendelser deraf | |
| PT1007717E (pt) | Processos e composicoes para terapias do cancro,utilizando genes que codificam o interferao-beta | |
| ATE174629T1 (de) | Herstellung von proteinen mittels protein 7b2 | |
| NO915084L (no) | Fremgangsmaate ved fremstilling av human interleukin-5 receptor | |
| DK0781344T3 (da) | Hidtil ukendt implantat og hidtil ukendt vektor til behandling af erhvervede sygdomme | |
| DE69910809D1 (de) | Verwendung von OmpA Enterobakterproteinen um zielgerichtet Antigen-Präsentierende Zellen anzusteuern | |
| BR9708005A (pt) | C3 convertase resistente à regulação para baixo | |
| PT870015E (pt) | Novas xilanases os genes que as codificam e as suas utilizacoes | |
| ATE355385T1 (de) | Herstellung von rekombinanten adenoviren und von adenovirus-genbanken | |
| NO941982L (no) | Fremstilling av proteiner ved anvendelse av 7B2 protein | |
| UA70909C2 (uk) | Рекомбінантний аденовірусний вектор, фармацевтична композиція, що його містить, та набір для зменшення проліферації пухлинних клітин | |
| MX9706569A (es) | Virus recombinantes que expresan la lecitina-colesterol aciltransferasa y sus usos en terapia genica. |